NCT02358304View on ClinicalTrials.gov

Efficacy of Nasal Spray Calcitonin on Recurrence of Aggressive Central Giant Cell Granuloma

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 28, 2015

Study Completion Date

April 30, 2015

Conditions
Central Giant Cell Granuloma
Interventions
DRUG

nasal spray calcitonin

recurrence rate of aggressive CGCG will be recorded after the use of nasal spray calcitonin

DRUG

Placebo

Trial Locations (1)

Unknown

Shiraz university of medical sciences, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT02358304 - Efficacy of Nasal Spray Calcitonin on Recurrence of Aggressive Central Giant Cell Granuloma | Biotech Hunter | Biotech Hunter